Publications

Design of the Randomized, Phase Iii, Quazar Aml Maintenance Trial of Cc-486 (Oral Azacitidine) Maintenance Therapy in Acute Myeloid Leukemia

AuthID
P-00K-4PP

Author(s)

Roboz, GJ

Montesinos, P

Selleslag, D

Wei, A

Jang, JH

Falantes, J

Voso, MT

Sayar, H

Porkka, K

Marlton, P

Almeida, A

Mohan, S

Ravandi, F

Garcia Manero, G

Skikne, B

Kantarjian, H

Document Type

Article

Year published

2016

Published

in FUTURE ONCOLOGY, ISSN: 1479-6694

Volume: 12, Issue: 3, Pages: 293-302 (10)

Indexing

Wos^®

Scopus^®

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.2217/fon.15.326

Scopus: 2-s2.0-84961348336

Wos: WOS:000368937200006

Source Identifiers

ISSN: 1479-6694

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Design of the Randomized, Phase Iii, Quazar Aml Maintenance Trial of Cc-486 (Oral Azacitidine) Maintenance Therapy in Acute Myeloid Leukemia

Useful Links

Get Help

Federated Authentication (Click on the image)

Design of the Randomized, Phase Iii, Quazar Aml Maintenance Trial of Cc-486 (Oral Azacitidine) Maintenance Therapy in Acute Myeloid Leukemia

Useful Links

Get Help